“IL-6 is a treatment target for a variety of immune diseases”– The benefit and prospect of IL-6 inhibitor

104

Views

CrossRef citations to date

Altmetric

"“IL-6 is a treatment target for a variety of immune diseases”– The benefit and prospect of IL-6 inhibitor –." Modern Rheumatology, 29(2), p. 257

Conflict of interest

None.

Additional information

Funding

Yutaka Kawahito has received speaking fee, honoraria and/or research grants from Chugai Pharmaceutical Co., Ltd. and Asahikasei Pharm Corp.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

“IL-6 is a treatment target for a variety of immune diseases”– The benefit and prospect of IL-6 inhibitor –

Information for

Open access

Opportunities

Help and information

“IL-6 is a treatment target for a variety of immune diseases”– The benefit and prospect of IL-6 inhibitor –

Conflict of interest

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature